| 2006 | Patient-reported assessment of quality care at end of life: Development and validation of Quality Care Questionnaire–End of Life (QCQ–EOL) | EUROPEAN JOURNAL OF CANCER |
| 2022 | Patient-reported distress and problems among elderly patients with hematological malignancy in Korea | SUPPORTIVE CARE IN CANCER |
| 2023 | Patient-Reported Health-Related Quality of Life in KEYNOTE-604: Pembrolizumab or Placebo Added to Etoposide and Platinum as First-Line Therapy for Extensive-Stage SCLC
| JTO Clinical and Research Reports |
| 2020 | Patient-reported outcome measures for diabetes self-care: A systematic review of measurement properties | INTERNATIONAL JOURNAL OF NURSING STUDIES |
| 2022 | Patient-reported outcomes (PROs) from DESTINY-Breast04, a randomized phase III study of trastuzumab deruxtecan (T-DXd) vs treatment of physician's choice (TPC) in patients (pts) with HER2-low metastatic breast cancer (MBC) | ANNALS OF ONCOLOGY |
| 2014 | Patient-Reported Outcomes From EMILIA, a Randomized Phase 3 Study of Trastuzumab Emtansine (T-DM1) Versus Capecitabine and Lapatinib in Human Epidermal Growth Factor Receptor 2-Positive Locally Advanced or Metastatic Breast Cancer | CANCER |
| 2020 | Patient-reported outcomes from FLAURA: Osimertinib versus erlotinib or gefitinib in patients with EGFR-mutated advanced non-small-cell lung cancer
| EUROPEAN JOURNAL OF CANCER |
| 2024 | Patient-reported outcomes of nipple reconstruction with a composite graft from the contralateral nipple
| ARCHIVES OF AESTHETIC PLASTIC SURGERY |
| 2020 | Patient-Reported Outcomes of Palbociclib Plus Exemestane with GnRH Agonist versus Capecitabine in Premenopausal Women with Hormone Receptor-Positive Metastatic Breast Cancer: A Prospective, Open-Label, Randomized Phase ll Trial (KCSG-BR 15-10)
| CANCERS |
| 2019 | Patient-reported outcomes with durvalumab after chemoradiotherapy in stage III, unresectable non-small-cell lung cancer (PACIFIC): a randomised, controlled, phase 3 study | LANCET ONCOLOGY |
| 2021 | Patient-Reported Outcomes with Durvalumab With or Without Tremelimumab Versus Standard Chemotherapy as First-Line Treatment of Metastatic Non-Small-Cell Lung Cancer (MYSTIC)
| CLINICAL LUNG CANCER |
| 2023 | Patient-reported outcomes with durvalumab, with or without tremelimumab, plus chemotherapy as first-line treatment for metastatic non-small-cell lung cancer (POSEIDON)
| LUNG CANCER |
| 2018 | Patient-Reported Toxicity During Pelvic Intensity-Modulated Radiation Therapy: NRG Oncology-RTOG 1203. | JOURNAL OF CLINICAL ONCOLOGY |
| 2019 | Patient-Specific Phantomless Estimation of Bone Mineral Density and Its Effects on Finite Element Analysis Results: A Feasibility Study
| COMPUTATIONAL AND MATHEMATICAL METHODS IN MEDICINE |
| 2018 | Patient-Specific Quality Assurance in a Multileaf Collimator-Based CyberKnife System Using the Planar Ion Chamber Array
| Korean Journal of Medical Physics (의학물리) |
| 2021 | Patient-Specific Quality Assurance Using a 3D-Printed Chest Phantom for Intraoperative Radiotherapy in Breast Cancer
| FRONTIERS IN ONCOLOGY |
| 2023 | Patient-specific virtual three-dimensional surgical navigation for gastric cancer surgery: A prospective study for preoperative planning and intraoperative guidance
| FRONTIERS IN ONCOLOGY |
| 2014 | Patients with Crohn's disease on anti-tumor necrosis factor therapy are at significant risk of inadequate response to the 23-valent pneumococcal polysaccharide vaccine | JOURNAL OF CROHNS & COLITIS |
| 2012 | Patients with early arthritis who fulfil the 1987 ACR classification criteria for rheumatoid arthritis but not the 2010 ACR/EULAR criteria | ANNALS OF THE RHEUMATIC DISEASES |
| 2019 | Patients with Inflammatory Bowel Disease Are at an Increased Risk of Parkinson's Disease: A South Korean Nationwide Population-Based Study
| Journal of Clinical Medicine |
